SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004249
Filing Date
2021-11-12
Accepted
2021-11-12 07:56:49
Documents
62
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vrca-20210930.htm   iXBRL 10-Q 2348699
2 EX-10.1 vrca-ex10_1.htm EX-10.1 327641
3 EX-31.1 vrca-ex31_1.htm EX-31.1 16147
4 EX-31.2 vrca-ex31_2.htm EX-31.2 16424
5 EX-32.1 vrca-ex32_1.htm EX-32.1 14864
  Complete submission text file 0000950170-21-004249.txt   8431341

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrca-20210930.xsd EX-101.SCH 43442
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrca-20210930_cal.xml EX-101.CAL 53674
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrca-20210930_def.xml EX-101.DEF 152876
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrca-20210930_lab.xml EX-101.LAB 413733
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrca-20210930_pre.xml EX-101.PRE 282909
11 EXTRACTED XBRL INSTANCE DOCUMENT vrca-20210930_htm.xml XML 1550579
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38529 | Film No.: 211399664
SIC: 2834 Pharmaceutical Preparations